Page 459 - Feline Cardiology

484 Index

Hypertrophic cardiomyopathy (HCM) with pulmonary interstitial pattern Hypocalcemia
(Cont’d) consistent with congestive heart arrhythmias and, 309
end-stage, 117 failure, lateral and ventrodorsal arterial thromboembolism and, 309
isovolumic relaxation and early views of cat with, 45 cardiac effects with, 248–249
diastolic filling in, 114–115 recommendations after genetic Hypochloremia , 296
passive diastolic filling in, 115 screening Hypokalemia, 296
resolution of left ventricular clear of HCM genetic mutation, 427 acute decompensation of cardiac or
hypertrophy in some cats, for treatment, 433–434 renal disease and, 371
117–118 indeterminate HCM mutation status, cardiac effects with, 245
SAM of the mitral valve, 116 427 hyperaldosteronism and, 405
differential diagnosis, 120–122 relationship of other cardiomyopathies premature ventricular complexes and, 229
drugs for, 433–434 with, 109–110 ventricular tachycardia and, 234
echocardiogram, 126–142 serum growth hormone, 150–151 Hyponatremia, 296
identification of SAM of the mitral severe Hyporexia, congestive heart failure and, 268
valve, 134–137 delayed enhancement seen on cMRI Hypotension, 338
left atrial size, 131–133 in cat with, 145, 145 anesthesia and treatment of, 419
left ventricular hypertrophy, 127–131 gross pathology and radiograph of in cats with left ventricular thickening,
overview, 127 cat with pleural effusion and, anesthetic management and, 413
pulsed-wave Doppler 271 low output heart failure and, 261
echocardiography, 137–139 M-mode echocardiogram showing syncope and, 13
tissue Doppler imaging, 139–142 left atrial dilation in cat with, 133 Hypothermia
echocardiography, conclusive diagnosis, pressure volume curves of cat with, arterial thromboembolism and poor
151–152 115 prognosis with, 308, 320
elevated SF% and, 58 thoracic radiographs of cat with excessive moderator bands and, 208
etiology of, in humans and molecular congestive heart failure and, 126 J wave/Osborn wave and, 250–251
mechanisms of, 106–109 signalment, 229, 426 low output heart failure and, 261
familial strain, left ventricular, Hypoxemia
in cats, 104, 106 echocardiographic and, 142 premature ventricular complexes and,
in people, sarcomeric proteins with syncope and, 15, 16, 17 229
mutations as cause of, 104 thyrotoxic heart disease concurrent pulmonary edema and, 291
experimental animal models of, 109 with, 399 ventricular tachycardia and, 234
genetic screening test, 148, 425–428 treatment of, 152–165, 433–434
gross pathology, 110–112 acute congestive heart failure in cats I
hallmark histologic abnormalities in, with, 162–164 IBD. See Inflammatory bowel disease
111, 263 asymptomatic cats, 152 Idiopathic dilated cardiomyopathy, 263
heart failure secondary to, negative beta blocker therapy, 156–157 shortest survival time for, 297
prognostic indicators for, 297 calcium channel blocker therapy, IE. See Infective endocarditis
history and chief complaint, 118–119 157–158 ILRs. See Implantable loop recorders
left ventricular pressure volume curve decision processes for asymptomatic Imidapril, 458
of normal cat and cat with, 263 cats with HCM, 152, 153–154t, indications, dosage, available sizes, 451
left ventricular wall measurements and, 154–155 references for, 468
criteria for, 127–131 neurohormonal antagonists in Implantable event recorders,
echocardiographic technique for asymptomatic HCM, 158–159 electrocardiography and, 81
obtaining, 57 outpatient treatment of symptomatic Implantable loop recorders,
normal values for comparison, inside cats with HCM, 160–162 electrocardiography and, 81
covers prophylactic anticoagulant therapy, Inderal (propranolol), 451
natriuretic peptides, 148–150 164–165 Idexx Cardiopet proBNP test, 73
cardiac troponin I, 150 refractory congestive heart failure, 164 Infective endocarditis, 197–200
endothelin 1, 150 suspected but not confirmed HCM, blood cultures and, 200
normal vs. forme fruste of, focal basilar 155–156 chronicity with, 198
concentric hypertrophy of symptomatic cats with severe HCM, diagnosis of, 199
interventricular septum and, 159–160 criteria for, 200t
129 Hypertrophic obstructive cardiomyopathy, major vs. minor criteria for, 199t
outcome and prognosis, 167 59, 105 pathogenesis of, 197
pathophysiology, 108, 112 kidney disease concurrent with, 369 pathologic bacteria associated with, 198
physical examination, 119–120 M-mode echocardiography showing prevalence of, 197
pleural effusion and, 19 normal mitral valve motion in therapy for, 199–200
premature ventricular complexes in cat normal cat vs. SAM of the Inflammation, biomarkers and, 69
with, 227 mitral valve in cat with, 136 Inflammatory bowel disease, 367
prevalence of, 105 murmur intensity and, 271 glucocorticoids and, 376–377